ritonavir

  1. Chandelier

    Real-world effectiveness of early nirmatrelvir/ritonavir initiation … against severe illness, hospitalization, death, and LC in N3C, 2026, Makkar

    Real-world effectiveness of early nirmatrelvir/ritonavir initiation after COVID-19 diagnosis in outpatient setting against severe illness, hospitalization, death, and long COVID in N3C Abstract Background COVID-19 has placed a monumental burden on the health care system globally. Although no...
  2. forestglip

    Nirmatrelvir/ritonavir use reduces risk for long COVID in patients with immunodeficiency, 2025, Gilbert et al

    Nirmatrelvir/ritonavir use reduces risk for long COVID in patients with immunodeficiency [Line breaks added] Selected paragraphs Our findings highlight the potential broad benefit of nirmatrelvir/ritonavir in reducing the risk of long COVID among patients with both primary and secondary...
  3. forestglip

    Efficacy Of SARS–CoV-2 Specific Antiviral Therapy for Enteroviral [ME/CFS], 2025, Chia et al

    Efficacy Of SARS–CoV-2 Specific Antiviral Therapy for Enteroviral Myalgic Encephalomyelitis/ChronicFatigue Syndrome John K Chia, David Wang Background Etiology remains elusive for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and no treatment exists. Antivirals had no efficacy...
Back
Top Bottom